ADC Therapeutics Announces Conference Presentations in September
ADC Therapeutics to Showcase Innovations at Investor Conferences
ADC Therapeutics SA (NYSE: ADCT), a prominent global entity in the realm of antibody drug conjugates (ADCs), is preparing to engage with investors at two significant conferences in the upcoming month. Set against the backdrop of their pioneering work, these presentations provide an exciting opportunity for stakeholders to gain insight into the future of cancer treatment.
Participation in Notable Events
During the H.C. Wainwright 26th Annual Global Investment Conference, taking place on September 9, 2024, Ameet Mallik, the Chief Executive Officer of ADC Therapeutics, will be discussing the company's latest advancements and strategic vision. This virtual fireside chat will begin at 7:00 a.m. ET.
Following that, ADC Therapeutics will also be featured at the 10th Cantor Global Healthcare Conference on September 18, 2024, from 11:30 to 12:00 p.m. ET. Here, Mallik will provide further insights into ADC Therapeutics’ promising developments in the field.
Accessibility of Presentations
Investors will have the opportunity to access live webcasts of both presentations through the Events & Presentations page located in the Investors section of the ADC Therapeutics website. Each presentation will also be available for replay for approximately 30 days following the events, ensuring that all interested parties can engage with the information shared.
Innovations at ADC Therapeutics
ADC Therapeutics is at the forefront of innovation in treating hematologic malignancies and solid tumors. The company’s primary product, ZYNLONTA (loncastuximab tesirine-lpyl), has achieved accelerated approval from the FDA, as well as conditional approval from European regulators. This treatment option is significant for patients experiencing relapsed or refractory diffuse large B-cell lymphoma after undergoing multiple therapeutic lines.
In addition to ZYNLONTA, the company is actively developing several ADCs, continuing to expand its portfolio and enhance its contributions to oncology.
Company Overview
Based in Lausanne, Switzerland, and with operations in London and New Jersey, ADC Therapeutics exemplifies commitment to transforming cancer care through innovation and expertise in ADC technology. The company's ongoing commitment is evident as they navigate through clinical and preclinical phases for a variety of ADC candidates.
Contact Information
For inquiries related to investments, please contact Marcy Graham at ADC Therapeutics via email at Marcy.Graham@adctherapeutics.com or by phone at +1 650-667-6450.
For media-related inquiries, please reach out to Nicole Riley at Nicole.Riley@adctherapeutics.com or call +1 862-926-9040.
Frequently Asked Questions
What is the focus of ADC Therapeutics?
ADC Therapeutics specializes in the development of antibody drug conjugates to treat various cancers, making significant strides in hematologic malignancies.
When are the investor conferences taking place?
The H.C. Wainwright conference is on September 9, 2024, followed by the Cantor Global Healthcare Conference on September 18, 2024.
How can I access the presentations?
Live webcasts of the presentations can be found on the ADC Therapeutics website in the Events & Presentations section, with replays available for 30 days afterward.
Who is leading the presentations?
Ameet Mallik, the Chief Executive Officer of ADC Therapeutics, will be leading the discussions at both conferences.
What is ZYNLONTA?
ZYNLONTA is ADC Therapeutics’ innovative treatment for relapsed or refractory diffuse large B-cell lymphoma, which has received accelerated approval from the FDA.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- LIFT Expands Cali Property Significantly Through Strategic Staking
- Middlefield Canadian Income PCC's Current Net Asset Value Insights
- Citi Predicts 125,000 Jobs in NFP, Foresees Fed Rate Cut
- Modest Predictive Growth in Canada Home Prices Amid Rate Cuts
- UK Home Prices Expected to Rise, Boosting First-Time Buyer Affordability
- Airlines Adjust Operations Amid Middle East Tensions
- UC Asset LP Announces Management-Driven Stock Buyback Plan
- NXG Cushing Midstream Energy Fund (NYSE: SRV) Announces New Distributions
- US Dollar Index Emerges as Key Factor for European Markets
- NXG NextGen Infrastructure Income Fund Announces New Distributions
- Constellation Brands Adjusts Earnings Outlook for 2025
- Corporate Profit Challenges: Earnings Outlook for 2025
- Bybit Powered by SATOS Launches Exclusive Trading Contest
- VSG Achieves Major Milestone with Coinstore Listing Today
- Opus Technologies Introduces Paysemble™ for Payment Solutions
- Bitcoin (BTC) Poised to Break $60,000 Barrier Soon
- QNB Corp. Successfully Completes $40 Million Subordinated Notes Offering
- Papaya Global Reinvents Payroll with Innovative Tech-First Solution
- Exploring the Projected Growth of the Augmented Analytics Market
- DMEX.APP Launches Cross Margin Positions for Traders
- Axiom Medical Welcomes Kevin Campbell as CFO to Lead Growth
- Real Estate Investment Trusts Drive Global Markets Upward
- Blue Federal Credit Union Achieves Prestigious Awards in 2024
- CaringBridge Welcomes New Board Members and Leadership Roles
- Healthcare Digital Twins Market to Surge 25.70% Growth Rate
Recent Articles
- Heritage Environmental Services Welcomes Patrick Schultz as Chief Officer
- Cambridge Judge Launches Family Business Leadership Programme
- Polarean Imaging Welcomes Alan Huang as VP of Sales
- GLOBO Language Solutions Explores AI in Medical Interpretation
- Object Management Group Launches New Journal of Innovation
- Monetary Metals Celebrates SOC 2 Certification Achievement
- Bango Partners with Disney+ to Expand Subscriber Offerings
- LM Funding America, Inc. Gears Up for H.C. Wainwright Conference
- Alexandria Real Estate Equities Announces Q3 2024 Results Call
- LeNae Goolsby's Journey: Reversing Biological Age Naturally
- Hearing Aids Market Projected to Reach $20.68 Billion by 2033
- Denali Therapeutics Plans Accelerated Approval for DNL310
- Kohl's vs. Visa: A Deep Dive into Dividends and Growth Potential
- Opthea's Upcoming Presentations at Investment Conferences
- Revival Gold Revamps Beartrack Earn-In Agreement Terms
- H World Group Limited Appoints New Chief Financial Officer
- Innovative Insights from Cold Spring Harbor Laboratory's Research
- Builtmore Contract Manufacturing Launches Isuzu NRR-EV Production
- Save Over £450 on Your Holiday Car Hire with Essential Tips
- Lowe's Companies: A Smart Investment as Elections Approach
- W&T Offshore Welcomes New General Counsel George Hittner
- Calibre Mining Reports Positive Results from Valentine Gold Mine
- NANO Nuclear Energy Inc. Class Action Lawsuit Update for Investors
- Industrial 3D Printing Market Projected to Reach $88 Billion
- GN Store Nord Share Transactions by Executives Unveiled